UCLH-6630 - LECANEMAB HOMECARE SERVICE
University College London Hospitals NHS Foundation Trust · £81,600 – £816,000 · closes 26 Mar 2025
£81,600 – £816,000
Estimated value
Closed
Deadline
5 Mar 2025
Published
This tender has closed.
See what's open in health and social care services, or get contracts like this in your inbox each morning — free.
About this contract
The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient's home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to provide this service. Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk
Key dates
Source
Who to contact
Tender documents
Similar open tenders
Contains public sector information licensed under OGL v3.0